Cytoreductive Nephrectomy for Synchronous Metastatic Renal Cell Carcinoma-Are There Any Favorable Risk Patients?

Hiten D. Patel; Joseph I. Clark; Robert C. Flanigan

doi:10.1097/JU.0000000000001656

Cytoreductive Nephrectomy for Synchronous Metastatic Renal Cell Carcinoma-Are There Any Favorable Risk Patients?

Hiten D. Patel, Joseph I. Clark, Robert C. Flanigan

Urology

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	4-6
Number of pages	3
Journal	The Journal of urology
Volume	206
Issue number	1
DOIs	https://doi.org/10.1097/JU.0000000000001656
State	Published - Jul 1 2021

Keywords

antineoplastic agents
carcinoma
cytoreduction surgical procedures
nephrectomy
renal cell

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/JU.0000000000001656

Cite this

@article{784ace0a211940a5a65d730126cb34f9,

title = "Cytoreductive Nephrectomy for Synchronous Metastatic Renal Cell Carcinoma-Are There Any Favorable Risk Patients?",

keywords = "antineoplastic agents, carcinoma, cytoreduction surgical procedures, nephrectomy, renal cell",

author = "Patel, {Hiten D.} and Clark, {Joseph I.} and Flanigan, {Robert C.}",

year = "2021",

month = jul,

day = "1",

doi = "10.1097/JU.0000000000001656",

language = "English (US)",

volume = "206",

pages = "4--6",

journal = "The Journal of urology",

issn = "0022-5347",